Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis

被引：0
|
作者：
Marx, Svetlana [1 ]
Harenberg, Job [1 ]
Wehling, Martin [1 ]
Weiss, Christel [2 ]
Diener, Hans-Christoph [3 ]
Marder, Victor J. [4 ]
Lip, Gregory Y. H. [5 ]
机构：
[1] Fac Med Mannheim, Dept Clin Pharmacol, D-68167 Mannheim, Germany
[2] Fac Med Mannheim, Dept Biometry & Stat, D-68167 Mannheim, Germany
[3] Univ Essen Gesamthsch, Dept Neurol, Essen, Germany
[4] UCLA Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[5] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
来源：
THROMBOSIS RESEARCH | 2012年 / 130卷
关键词：
D O I：
10.1016/j.thromres.2012.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [1] Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation
    Marx, S.
    Diener, H. -C.
    Harenberg, J.
    Lip, G.
    Marder, V.
    Wehling, M.
    Weiss, C.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 815 - 815
  • [2] Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis
    Harenberg, J.
    Marx, S.
    Diener, H. -C.
    Lip, G. Y. H.
    Marder, V. J.
    Wehling, M.
    Weiss, C.
    [J]. INTERNATIONAL ANGIOLOGY, 2012, 31 (04) : 330 - 339
  • [3] Efficacy and Safety of Dabigatran, Rivaroxaban, and Apixaban Compared to Warfarin in Asian Patients With Non-valvular Atrial Fibrillation: A Systemic Review and Meta-analysis
    Li, Weijia
    Kokkinidis, Damianos
    Wang, Yu Chiang
    [J]. CIRCULATION, 2020, 142
  • [4] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [5] Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
    Li, Wei-Jia
    Archontakis-Barakakis, Paraschos
    Palaiodimos, Leonidas
    Kalaitzoglou, Dimitrios
    Tzelves, Lazaros
    Manolopoulos, Apostolos
    Wang, Yu-Chiang
    Giannopoulos, Stefanos
    Faillace, Robert
    Kokkinidis, Damianos G.
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (04): : 82 - 94
  • [6] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Ashley Prentice
    Irene Ruiz
    Erin R. Weeda
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 49 : 360 - 364
  • [7] Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
    Choi, E. -K.
    Lee, S. R.
    Kwon, S.
    Han, K. D.
    Jung, J. H.
    Oh, S.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2986 - 2986
  • [8] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Prentice, Ashley
    Ruiz, Irene
    Weeda, Erin R.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (03) : 360 - 364
  • [9] Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis
    Memon, Rahat A.
    Hamdani, Syed Shah Qasim
    Usama, Ali
    Aisha, F. N. U.
    Kundi, Hayan
    Mathavan, Mohit
    Khalid, Malaika
    Khan, Areeba
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [10] Comparison of Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban in Patients With Valvular Atrial Fibrillation: A Network Meta-Analysis of Randomized-Control Trials and Observational Studies
    Huma, Huria
    Rawat, Anurag
    Kaur, Mandeep
    Jha, Omkar
    Gill, Fahad Shaukat
    Moqattash, Merid
    Wei, Calvin R.
    Allahwala, Danish
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
12345